ANDREW BRAKE: Open Payments
NPI 1174022743 · GREENSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$595 in 36 payments from 12 companies in 2025. Trend: 2023 $67 · 2024 $1,392 · 2025 $595
Food & beverage: $595
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 11 | $156 |
| Lilly USA, LLC | 8 | $147 |
| AstraZeneca Pharmaceuticals LP | 4 | $63 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $44 |
| GlaxoSmithKline, LLC. | 2 | $44 |
| Novo Nordisk Inc | 2 | $30 |
| Exact Sciences Corporation | 1 | $23 |
| Esperion Therapeutics, Inc. | 1 | $23 |
| Abbott Laboratories | 1 | $22 |
| Merck Sharp & Dohme LLC | 1 | $15 |
Products named: MOUNJARO, NURTEC ODT, JARDIANCE, FARXIGA, AIRSUPRA, ELIQUIS, PREVNAR 20, ZEPBOUND.
Industry payments across NC — which companies pay providers there.
